Published online June 2, 2008
PEDIATRICS Vol. 121 No. 6 June 2008, pp. e1570-e1576 (doi:10.1542/peds.2007-2446)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nemes, E.
Right arrow Articles by Korponay-Szabó, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nemes, E.
Right arrow Articles by Korponay-Szabó, I. R.
Related Collections
Right arrow Gastrointestinal Tract
Right arrowRelated AAP Red Book topics:
Hepatitis B
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Gluten Intake Interferes With the Humoral Immune Response to Recombinant Hepatitis B Vaccine in Patients With Celiac Disease

Éva Nemes, MDa, Éva Lefler, MDb, László Szegedi, MDc, Anikó Kapitány, MScd, Judit B. Kovács, MD, PhDe, Márta Balogh, MDf, Katalin Szabados, MDg, Judit Tumpek, MDd, Sándor Sipka, MD, PhDd and Ilma R. Korponay-Szabó, MD, PhDe,h

a Department of Pediatrics
d Third Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary
b Laboratory of National Public Health and Medical Services, Debrecen, Hungary
c Department of Internal Medicine, Kenézy Gyula County Hospital, Debrecen, Hungary
e Department of Gastroenterology-Nephrology, Heim Pál Children's Hospital, Budapest, Hungary
f Department of Pediatrics, Markusovszky Hospital, Szombathely, Hungary
g Department of Infectology, Hetényi Géza County Hospital, Szolnok, Hungary
h Pediatric Research Center, University of Tampere Medical School, Tampere, Finland

OBJECTIVE. Patients with celiac disease, who often carry human leukocyte antigen-DR3;DQ2, are prone to inadequate response to hepatitis B immunization. We evaluated vaccine response in relation to disease activity and whether previous treatment with a gluten-free diet influences the achievement of protective antibody titers.

PATIENTS AND METHODS. We studied 128 children and adolescents with celiac disease and 113 age-matched control subjects. Twenty-two patients with celiac disease were prospectively immunized after diagnosis during dietary treatment (group 1). A total of 106 (group 2) and the control subjects received vaccination by mass immunization in schools at 14 years of age regardless of diet status and when celiac disease was still undiagnosed in 27 of these children. Diet compliance and celiac disease activity were monitored by measurement of antibodies against transglutaminase and endomysium. Vaccine response was determined by measuring antihepatitis B antibodies from serum.

RESULTS. The seroconversion after hepatitis B vaccination was 95.5% in group 1. All of these patients carried human leukocyte antigen DQ2. The response rate in group 2 was 50.9% and correlated with gluten intake (untreated patients: 25.9%, non-strict diet: 44.4%, strict diet: 61.4%). Treated and compliant patients did not significantly differ from control subjects (75.2%). Thirty-seven antihepatitis B–negative patients with celiac disease received a booster during a controlled gluten-free diet, and 36 (97.3%) seroconverted, irrespective of the presence of human leukocyte antigen DQ2.

CONCLUSIONS. Nonresponse to recombinant hepatitis B surface antigen may be a sign of undiagnosed celiac disease. However, there is a good vaccine response in adequately treated patients. Human leukocyte antigen DQ alleles do not seem to have a primary role. Revaccination is recommended during a controlled gluten-free diet.

Key Words: celiac disease • gluten-free diet • hepatitis B immunization • vaccine nonresponse • endomysium antibody • transglutaminase antibody • disease activity

Abbreviations: HBV—hepatitis B virus • HBsAg—hepatitis B surface antigen • HLA—human leukocyte antigen • CD—celiac disease • TG2—type 2 transglutaminase • anti-HBs—antihepatitis B surface antibody • HBe—hepatitis B envelope • Ig—immunoglobulin • EMA—endomysium antibody • CI—confidence interval

Accepted Nov 14, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


eLetters:

Read all eLetters

Hepatitis B vaccine nonresponse in healthy and celiac children. Efficacy of single booster dose
Javier Blasco Alonso, et al.
Pediatrics Online, 3 Aug 2009 [Full text]